In the News

In Dr James Le Fanu’s online health clinic, published in the Daily Telegraph on Tuesday 28 June 2016, visitors were directed to Lab Tests Online-UK as a result of a letter submitted to the online health clinic. A reader wrote to inform Dr Le Fanu of the website, and described it as a useful, respectable source of information, endorsed by the Royal College of Pathologists.

NICE has recommended any of four commercial placental growth factor (PLGF) based blood tests to cost-effectively help both ‘rule in’ and ‘rule out’ suspected pre-eclampsia in late pregnancy.

The World Health Organization (WHO) released recommendations on 12 May 2016 that aim to speed up the detection, and improve the treatment of multidrug resistant tuberculosis (MDR-TB). A novel molecular diagnostic test is recommended for use in national TB reference laboratories that can identify genetic mutations in MDR-TB strains within 24 – 48 hours and reliably rule out resistance to second-line TB drugs. Early detection of MDR-TB has been one of the major bottlenecks in tackling the global TB epidemic.

Symptom-free carriers of C difficile admitted to hospital can potentially transmit the bacterium to other patients. Research workers from Québec, Canada took rectal swabs from 7599 patients admitted to their hospital from the emergency department to identify those carrying C difficile from its tcdB gene that codes for B toxin. The 368 (4.8%) who had a positive test result were placed in modified contact isolation. The researchers reported online in JAMA Intern Med on 25 April 2016 that, over the 15 months after the introduction of this intervention, the incidence of hospital-acquired C difficile infection decreased to less than half that experienced during the previous six years, falling from 6.9 to 3.0 cases per 10,000 patient-days.

The UK National Screening Committee published recommendations on 15 January 2016 for improvements to three of the NHS screening programmes that use lab tests. The committee advised that a faecal immunochemical test (FIT) should replace the guaiac occult blood test as the primary test for bowel cancer because it detects more cases and is easier to use. a test for human papilloma virus (HPV) should replace the liquid cytology test as the first line screen for cervical cancer because it is more accurate. a non-invasive prenatal test (NIPT) on maternal blood should be evaluated as a second screen for pregnant women whose initial screen suggests their baby has an increased chance of having Down’s syndrome. NIPT greatly improves accuracy, so that fewer women would need an invasive procedure to make a firm diagnosis.

A recent study published in the New England Journal of Medicine describes a 21-gene test performed on tumour tissue removed from women with certain types of breast cancer. Results suggest that the test can accurately predict those women who will do well with hormone treatment, without the need for chemotherapy.

Researchers carried out high-sensitivity cardiac troponin blood tests on 4,870 patients arriving as emergencies at four Scottish hospitals with a suspected heart attack. Their retrospective analysis of the results was reported online in The Lancet on 8 October 2015. In the 3,799 patients who had no electrocardiogram (ECG) evidence of a heart attack and a normal troponin test result on admission, the researchers identified a specific troponin concentration within the normal reference range, below which 99.6% of the patients were not subsequently diagnosed with a heart attack and had therefore been eligible for early discharge. It is hoped that using this approach will substantially reduce hospital admissions and have major benefits for both patients and health-care providers.

AACC, a global scientific and medical professional organisation dedicated to better health through laboratory medicine, is pleased to announce that it has been honoured with a 2015 ASAE Power of A Gold Award for Lab Tests Online.

The earlier cancer is diagnosed the more likely is treatment to be successful. In June 2015 the National Institute for Health and Care Excellence (NICE) published an updated guideline for general practitioners so that the signs and symptoms of possible cancers could be recognised earlier and the right tests performed faster. It also produced information to help the general public recognise common signs and symptoms of possible cancer so that people would visit their doctor sooner. Health experts predict earlier diagnosis may save thousands of lives each year.

The charity, Sense About Science, has released a new edition of their guide, Making Sense of Screening, today. The aim of the guide is to provide the public with valuable information to improve their understanding of screening programmes and to address the sometimes unrealistic expectations of what screening can deliver.